The novel therapy of tirzepatide peptide represents a major advance in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide016902.activosblog.com/40543930/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment